You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中新藥業(600329.SH):津滬深醫藥要約收購公司股份交割完成
格隆匯 05-11 15:57

格隆匯5月11日丨中新藥業(600329.SH)公佈,公司於2021年3月29日公吿了《天津中新藥業集團股份有限公司要約收購報吿書》,津滬深醫藥向除天津市醫藥集團有限公司所持股份以外的中新藥業全部無限售條件流通A股股份發出全面收購要約,要約收購期限為2021年3月31日至2021年4月29日。

截至2021年4月29日,本次要約收購期限屆滿。根據中國證券登記結算有限責任公司上海分公司提供的數據統計,在要約收購期限間,最終有3個賬户,共計4497股股份接受津滬深醫藥發出的要約。

收購人已按照上海證券交易所和中登公司上海分公司的有關規定履行了相關義務。截至2021年5月11日,本次要約收購清算過户手續已經辦理完畢,津滬深醫藥直接及間接持有公司股份3.31億股,佔公司總股本的42.80%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account